Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.82 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.82 |
| ▸ | TST | Q16762 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.82 |
| ▸ | RECQL | P46063 | 1/20 | 0.82 |
| ▸ | BLM | P54132 | 1/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.82 |
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | DGKA | P23743 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.49 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.49 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8163824 | 1.00 | HSPD1 (0.82) | HSPD1HSPE1TSTMAPTRECQL | |
| Ascorbyl Gamolenate SCHEMBL3142843 | 0.99 | HSPD1 (0.80) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL2241479 | 0.97 | MAPT (0.76) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL14880173 | 0.97 | HSPD1 (0.87) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL9722188 | 0.91 | HSPD1 (0.67) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL24511445 | 0.90 | MAPT (1.00) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL22749133 | 0.90 | MAPT (1.00) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL22749131 | 0.90 | MAPT (1.00) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL22749146 | 0.90 | MAPT (1.00) | HSPD1HSPE1TSTMAPTRECQL | |
| SCHEMBL1762372 | 0.90 | MAPT (1.00) | HSPD1HSPE1TSTMAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5078989-A | Linoleic Acid-Vitamin C Esters | SUNSTAR K.K. (JP) | 1992-01-07 | — | — | US | claimed |
| WO-2024129968-A1 | INJECTABLE COMPOSITIONS FOR TREATING JOINT CONDITIONS | OHIO STATE INNOVATION FOUNDATION (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20220118159-A1 | ANTIOXIDANT-RELEASING VITREOUS SUBSTITUTES AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION | 2022-04-21 | — | — | US | disclosed |
| EP-3920986-A1 | ANTIOXIDANT-RELEASING VITREOUS SUBSTITUTES AND USES THEREOF | Ohio State Innovation Foundation (US) | 2021-12-15 | — | — | EP | disclosed |
| CN-113646014-A | Antioxidant-releasing vitreous substitute and use thereof | 俄亥俄州创新基金会 | 2021-11-12 | — | — | CN | disclosed |
| WO-2020163872-A1 | ANTIOXIDANT-RELEASING VITREOUS SUBSTITUTES AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2020-08-13 | — | — | WO | disclosed |
| US-9295630-B2 | Vitamin C complexes | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-03-29 | — | — | US | disclosed |
| US-9289428-B2 | Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer | RAMSCOR, INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-20150045426-A1 | VITAMIN C COMPLEXES | Universite Paris-Saclay (FR) | 2015-02-12 | — | — | US | disclosed |
| US-20140329785-A1 | Conveniently Injectable or Implantable Sustained-Release Antioxidant Formulations for Therapies of Ocular Maladies or Cancer | RAMSCOR, INC. (US) | 2014-11-06 | — | — | US | disclosed |
| EP-2717866-A2 | CONVENIENTLY INJECTABLE OR IMPLANTABLE SUSTAINED-RELEASE ANTIOXIDANT FORMULATIONS FOR THERAPIES OF OCULAR MALADIES OR CANCER | Ramscor, Inc. (US) | 2014-04-16 | — | — | EP | disclosed |
| WO-2013058838-A2 | CONVENIENTLY INJECTABLE OR IMPLANTABLE SUSTAINED-RELEASE ANTIOXIDANT FORMULATIONS FOR THERAPIES OF OCULAR MALADIES OR CANCER | WONG VERNON G (US) | 2013-04-25 | — | — | WO | disclosed |
| US-5078989-A | Linoleic Acid-Vitamin C Esters | SUNSTAR K.K. (JP) | 1992-01-07 | — | — | US | disclosed |
| EP-0296483-A2 | Preparation of ascorbic acid 6-esters | F. HOFFMANN-LA ROCHE AG (CH) | 1988-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045426-A1 | VITAMIN C COMPLEXES | PROC, CYP27B1, CYP24A1 | HSPD1 507/4885HSPE1 364/4885TST 2584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.